Should Human Cancer Genes Be Owned and Controlled by Legal Monopolies? | Cancer Articles for Facebook | Scoop.it
Gayle Sulik says the reason the BRCA1 gene mutation test for breast cancer risk is so expensive is that a company owns the gene and sets the price.

Via Graham Player Ph.D.